Acquisition / mergerNotableFiled on BSE ·

Anupam Rasayan opens open offer for 26% of Bliss GVS Pharma at ₹299 per share

Bliss GVS Pharma

Arthneeti Research DeskPublished 1 min read
26%Acquisition / merger

Key highlights

  • Open offer by Anupam Rasayan India for up to 2,77,26,848 shares (26.00%) at ₹299.00 per share, triggered by SPA dated 23 May 2026.
  • Escrow Amount of ₹ 160,00,00,000.00 maintained with Axis Bank Limited under the Escrow Agreement dated 26 May 2026.
  • Expanded Voting Share Capital is 10,66,41,722 Equity Shares, expected as of the 10th Working Day after the Tendering Period closes.

Why it's rated notable: amount is ₹500 crore or more

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

Draft Letter of Offer

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Bliss GVS Pharma

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.